天津医药 ›› 2021, Vol. 49 ›› Issue (4): 378-384.doi: 10.11958/20202229

• 实验研究 • 上一篇    下一篇

黄芪甲苷调控线粒体自噬减轻5-Fu诱导老龄大鼠心肌毒性的实验研究#br#

李沅洋,周湘忠,雷向红,张宇凡,徐月,魏丽萍   

  1. 1天津中医药大学研究生院(邮编3000193);2天津市人民医院心脏内科;3天津滨海新区大港医院心脏内科;4天津市人民医院超声科;5天津医科大学研究生院
  • 收稿日期:2020-08-04 修回日期:2020-11-14 出版日期:2021-04-15 发布日期:2021-04-16
  • 通讯作者: 魏丽萍 E-mail:weilipingme@163.com
  • 作者简介:李沅洋(1988),女,硕士,住院医师,主要从事抗代谢类化疗药物心脏毒性方面研究。E-mail:Liyuanyong2000@126.com
  • 基金资助:
    天津滨海新区卫生健康委员会科技重点支持项目(2019BWKZ004);京津冀基础研究合作专项(19JCZDC63900)

The experimental study on astragaloside Ⅳ regulating mitochondrial autophagy to reduce myocardial toxicity induced by 5-Fu in aging rats

LI Yuan-yang1, 2, ZHOU Xiang-zhong3, LEI Xiang-hong4, ZHANG Yu-fan2, 5, XU Yue1, 2, WEI Li-ping2△   

  1. 1 Graduate School of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; 2 Department of Cardiology, Tianjin Union Medical Center; 3 Department of Cardiology, Tianjin Binhai New Area Dagang Hospital; 4 Department of Ultrasound, Tianjin Union Medical Center; 5 Graduate School of Tianjin Medical University
  • Received:2020-08-04 Revised:2020-11-14 Published:2021-04-15 Online:2021-04-16
  • Contact: WEI Li-ping E-mail:weilipingme@163.com

摘要: 目的 探索黄芪甲苷(AS-Ⅳ)通过PINK1/Parkin信号通路调控自噬减轻5-氟尿嘧啶(5-Fu)诱导老龄大鼠心肌毒性的疗效及机制。方法 18月龄雄性SD大鼠36只,按随机数字表法分为对照组、模型组、AS-Ⅳ组,每组12只。以5-Fu注射液30 mg/kg,腹腔注射,隔日1次,连续7次建立模型组;AS-Ⅳ稀释液,20 mg/kg,灌胃,每日1次,连续14次,建立AS-Ⅳ组。检测血清肌钙蛋白I(cTnI)、肌酸激酶同工酶(CK-MB)、心肌线粒体腺苷三磷酸(ATP)及膜电位水平、行HE及Masson染色观察心肌病理改变、免疫荧光染色检测微管相关蛋白LC3Ⅱ表达、电镜观察线粒体结构并采用Western blot检测PINK1/Parkin通路关键分子PINK1、Parkin、Beclin1、LAMP、LC3蛋白表达。结果 与模型组相比,AS-Ⅳ可减缓大鼠体质量下降,降低心肌cTnI及CK-MB水平,抑制线粒体ATP水平下降(P<0.05)。与对照组相比,模型组心肌纤维排列紊乱,胶原纤维沉积,胶原容积百分比升高;经AS-Ⅳ干预后,胶原容积百分比减低(P<0.05)。电镜及LC3Ⅱ荧光染色显示,经AS-Ⅳ干预后,线粒体损伤程度减轻,LC3Ⅱ表达量减低(P<0.05)。Western blot结果提示AS-Ⅳ苷干预后Beclin1、PINK1、Parkin、LAMP和LC3Ⅱ/Ⅰ表达较模型组降低(P<0.05)。结论 5-Fu可诱导心肌线粒体损伤,线粒体自噬过度,AS-Ⅳ可通过调节自噬减轻5-Fu心肌毒性。

关键词: 氟尿嘧啶, 黄芪甙, 线粒体, 自噬, 衰老, 心脏毒性, 黄芪甲苷, PINK1/Parkin信号通路

Abstract: Objective To investigate the effect and mechanism of astragaloside Ⅳ (AS-Ⅳ) regulating autophagy to reduce 5-fluorouracil (5-Fu) induced myocardial toxicity based on PINK1/Parkin signaling pathway in the rats. Methods Thirty-six male SD rats aged 18 months were divided into control group, model group and AS-Ⅳ group by random number table method, with 12 rats in each group. The rat model was administered the intraperitoneal injection of 30 mg/kg 5-Fu every other day for 7 times. The intervention group was administered the intragastrical 20 mg/kg AS-Ⅳ diluent every day for 14 times. The serum levels of troponin I (cTnI), creatine kinase isoenzyme (CK-MB), myocardial mitochondrial ATP and membrane potential were measured. HE and Masson staining were used to evaluate the pathological changes of myocardium. The expression of microtubule-associated protein (LC3Ⅱ) was evaluated by immunofluorescence. The ultrastructure of mitochondria was observed under electron microscope. The protein expressions of PINK1/Parkin pathway (key molecules PINK1, Parkin, Beclin1, LAMP and LC3) were detected by Western blot assay. Results Compared with the model group, AS-Ⅳ could slow down the weight loss (P<0.05), reduce the secretion of myocardial enzyme cTnI and CK-MB (P<0.05) and inhibit the decrease of mitochondrial ATP levels (P<0.05). Compared with control group, the myocardial fibers were disorderly arranged and a large number of blue collagen fibers were deposited in the model group. After the intervention of AS-Ⅳ, the collagen volume fraction decreased in the model group (P<0.05). Electron microscopy and LC3Ⅱ fluorescence labeling showed that after AS-Ⅳ intervention, the degree of mitochondrial damage was reduced and the expression of LC3Ⅱ was decreased (P<0.05). Western blot results indicated that Beclin1, PINK1, Parkin, LAMP and LC3Ⅱ/Ⅰ expression levels were significantly reduced (P<0.05). Conclusion The 5-Fu induces myocardial mitochondrial injury and excessive cardiac mitochondrial autophagy, and AS-Ⅳ alleviates it by regulating autophagy 5-Fu myocardial toxicity. 

Key words: fluorouracil, Astragalin, mitochondria, autophagy, aging, cardiotoxicity, astragaloside Ⅳ, PINK1/Parkin signaling pathway

中图分类号: